Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001346824-25-000066·Benitec Biopharma Inc.
Schedule 13G ownership disclosure
Benitec Biopharma Inc
Common Stock, par value $0.0001 per share · CUSIP: 08205P209
Event date: 2025-11-07
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.
Shares: 1,850,000.00 · Class: 5.5%
- Peter Kolchinsky
Shares: 1,850,000.00 · Class: 5.5%
- Rajeev Shah
Shares: 1,850,000.00 · Class: 5.5%
- RA Capital Healthcare Fund, L.P.
Shares: 1,850,000.00 · Class: 5.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001346824-25-000066
- Form type
- SCHEDULE 13G
- Filer
- Benitec Biopharma Inc.
- CIK
- CIK 1808898
- Filed
- Dec 03, 2025
- Reporting period
- Nov 07, 2025
- Description
- Schedule 13G beneficial ownership